Elevance Health, Inc. (ELV) — Form 8-K: Current report

Elevance Health, Inc. filed a current report to announce that officers expect to speak with investors this week. Company officers will reaffirm full year 2026 shareholders' earnings guidance of at least $22.00 per diluted share and adjusted earnings of at least $29.00 per diluted share. They also reaffirmed the full year 2026 benefit expense ratio guidance of 90.2% plus or minus 50 basis points.